POST-STROKE HYPERGLYCAEMIA – TREATMENT WITH EXENATIDE IN ACUTE ISCHAEMIC STROKE (TEXAIS) TRIAL
Grant number: 1126070 | Funding period: 2017 - 2021
Raised blood glucose levels (hyperglycaemia) after a stroke is common. It reduces the efficacy of stroke treatments and results in worse outcomes. Insulin is not useful as a treatment for this as it causes frequent hypoglycaemia and does not improve clinical outcomes. Exenatide is a common diabetes drug that is simple to use and lowers blood glucose without hypoglycaemia. It will be tested in the Treatment with Exenatide in Acute Ischaemic Stroke (TEXAIS) trial.